IRay

· Oraya Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for IRay, covering 2011-12-30 to 2012-11-01. Get the full timeline:

Most recent: Clinical Trial Update: IRay to Treat Polypoidal Choroidal Vasculopathy (PCV) Secondary to Age-Related Macular Degeneration (AMD [NA]